CRITICAL CARE AND RESUSCITATION | INFUSION THERAPY | DIALYSIS | PAIN THERAPY

 

DURALOCK-C

Trisodium Citrate catheter lock solution

DuraLock-C™ : Trisodium citrate - reduces infections and thrombosis catheter related. 
Pre-filled syringes, packaged in fully sterile sets and available in 3 different concentration: 46.7%, 30% e 4%.

Register and download the brochure
Request technical information

DuraLock-C™: Trisodium citrate solution in water, is the most effective lock solution for CVCs to prevent:

  • Clotting / Biofilm
  • Infections


Wide range of product

In order to fulfill customer needs, DuraLock-C™ is available in 3 different concentration:

  • Duralock-C 46.7%
  • Duralock-C 30%
  • Duralock-C 4%


WHY DURALOCK-CTM?

  • Strong antithrombotic
  • No systemic and non-toxic effects
  • Prevents biofilm formation
  • Broad-spectrum anti-bacterial effect
  • No development of drug-resistant bacteria
  • Less catheter infections
  • Less coagulation in the catheters
  • Less use of Urokinase and antibiotics
  • Less waiting time (start of treatment)
  • Less flow issues
  • Less hospitalization
  • Less interruption of dialysis treatments


Effective Packaging

  • PRE-FILLED SYRINGES: each set include a pair of 3 ml syringe -arterial and venous; each syringe contains 2.5 ml of product.
  • Both syringes are luer-type and are packaged in a fully sterile Tyvek® bag.
  • The completely sterile pair of syringes reduces the risk of nosocomial infections compared to the classic vial packaging.
     

References

(1) Ash SR, Mankus RA, Sutton JM, Criswell RE, Crull CC, Velasquez KA, Smeltzer BD, Ing TS: Concentrated sodium citrate (23%) for catheter lock. Hemodial Int 4: 22-31, 2000

(2) Weijmer MC, Debets-Ossenkopp YJ, van de Vondervoort FJ, ter Wee PM: Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 17:2189-2195, 2002

(3) Bayés B, Bonal J, Romero R: Sodium citrate for filling haemodialysis catheters. Nephrol Dial Transplant 14: 2532-2533, 1999

(4) Weijmer MC, et al: Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J. Am. Soc. Nephrol., 16: 2769 – 2777, 2005
 






Producer Medcomp Medcomp


To download the data sheet, you need to access the restricted area:

Forgot password? Click here



Not registered?

Register now

Request technical information (dedicated to professionals)

Fill in this form to request more technical / clinical information on DURALOCK-C

Authorize Seda s.p.a. and its subsidiaries or related to the processing of personal data for purposes related to the service and to send you promotional material, in the manner described in Information on the processing of personal data (POLICY) *



Seda, reliability is our goal

We only supply devices in compliance with MDD 93/42/EC and validated by our internal regulatory department.


Our certifications